Prelude Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-6,600
| Closed | -$83K | – | 1919 |
|
|
2017
Q1 | $83K | Sell |
6,600
-69,360
| -91% | -$872K | 0.01% | 797 |
|
|
2016
Q4 | $1.01M | Buy |
75,960
+3,704
| +5% | +$49.1K | 0.12% | 195 |
|
|
2016
Q3 | $1.71M | Buy |
72,256
+69,173
| +2,244% | +$1.64M | 0.18% | 122 |
|
|
2016
Q2 | $89K | Buy |
3,083
+2,083
| +208% | +$60.1K | 0.01% | 762 |
|
|
2016
Q1 | $32K | Sell |
1,000
-1,400
| -58% | -$44.8K | ﹤0.01% | 970 |
|
|
2015
Q4 | $103K | Buy |
2,400
+1,600
| +200% | +$68.7K | 0.02% | 746 |
|
|
2015
Q3 | $28K | Sell |
800
-500
| -38% | -$17.5K | ﹤0.01% | 1109 |
|
|
2015
Q2 | $60K | Buy |
+1,300
| New | +$60K | 0.01% | 1019 |
|
|
2014
Q3 | – | Sell |
-1,400
| Closed | -$42K | – | 2135 |
|
|
2014
Q2 | $42K | Buy |
+1,400
| New | +$42K | 0.01% | 1295 |
|
|
2014
Q1 | – | Sell |
-3,684
| Closed | -$93K | – | 2033 |
|
|
2013
Q4 | $93K | Buy |
+3,684
| New | +$93K | 0.02% | 787 |
|